AJANTPHARM — Ajanta Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Ajanta Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	28,897	33,410	37,426	42,087	46,481
Cost of Revenue
Gross Profit	22,073	24,543	26,259	30,934	35,210
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	20,050	25,331	30,620	31,561	35,196
Operating Profit	8,847	8,079	6,806	10,526	11,285
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	9,002	9,095	7,453	11,139	11,892
Provision for Income Taxes
Net Income After Taxes	6,539	7,127	5,880	8,162	9,204
Net Income Before Extraordinary Items
Net Income	6,539	7,127	5,880	8,162	9,204
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6,539	7,127	5,880	8,162	9,204
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	50.6	55.4	46.3	65	73.6
Dividends per Share
Special Dividends per Share